Efficacy of different platforms in detecting EGFR mutations using cerebrospinal fluid cell‐free DNA from non‐small‐cell lung cancer patients with leptomeningeal metastases

BACKGROUND: Cell‐free tumor DNA (ctDNA) obtained through liquid biopsy is useful for the molecular analysis of advanced non‐small‐cell lung cancer (NSCLC). Few studies have directly compared analysis platforms in terms of their diagnostic performance in analyzing ctDNA obtained from the cerebrospina...

Descripción completa

Detalles Bibliográficos
Autores principales: Chiang, Chi‐Lu, Ho, Hsiang‐Ling, Yeh, Yi‐Chen, Lee, Cheng‐Chia, Huang, Hsu‐Ching, Shen, Chia‐I, Luo, Yung‐Hung, Chen, Yuh‐Min, Chiu, Chao‐Hua, Chou, Teh‐Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10175033/
https://www.ncbi.nlm.nih.gov/pubmed/36977550
http://dx.doi.org/10.1111/1759-7714.14866

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10175033/
https://www.ncbi.nlm.nih.gov/pubmed/36977550
http://dx.doi.org/10.1111/1759-7714.14866

Ejemplares similares